{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-045127","form_type":"8-K","ticker":"LIMN","cik":"0001971387","company_name":"Liminatus Pharma, Inc.","filed_at":"2025-05-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.598132+00:00","generated_at":"2026-05-22T14:36:49.787318+00:00","sec_items":["1.01","2.01","5.02","3.02","4.01","9.01","3.03","5.01","5.03","5.05","5.06","7.01","8.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Liminatus Pharma completes de-SPAC merger, receives $15M PIPE, begins Nasdaq trading","bullets":["Closed de-SPAC merger with Iris Acquisition Corp; issued 17.5M shares at $10/share ($175M equity value) to Liminatus securityholders.","Concurrent $15M PIPE investment (1.5M shares at $10) from accredited investor.","Sponsor forfeited 4.18M private placement warrants; 59,844 public shares redeemed for ~$702k.","Liminatus Pharma, a pre-clinical CD47 checkpoint inhibitor developer, reported FY2024 net loss of $3.5M, accumulated deficit $28.7M.","Common stock (LIMN) and warrants (LIMNW) began trading on Nasdaq May 1, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-045127","json":"https://secwatch.observer/filing/0001104659-25-045127.json","markdown":"https://secwatch.observer/filing/0001104659-25-045127.md","text":"https://secwatch.observer/filing/0001104659-25-045127.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925045127/0001104659-25-045127-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925045127/tm2513673d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T14:36:49.787318+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}